SV40 Small Tumor Antigen Activates Key Signaling Pathways in Human Cells
Author Information
Author(s): Ali-Seyed Mohamed, Laycock Noelani, Karanam Suresh, Xiao Wenming, Blair Eric T, Moreno Carlos S
Primary Institution: Emory University School of Medicine
Hypothesis
Does SV40 small tumor antigen (ST) affect gene expression and signaling pathways in human cells?
Conclusion
SV40 ST expression alters cell survival pathways, making cells more sensitive to Hedgehog pathway inhibitors.
Supporting Evidence
- The AB platform identified 3478 genes affected by SV40 ST, significantly more than the Affymetrix platform.
- Inhibitors of Hedgehog signaling were found to kill cells expressing SV40 ST.
- Notch signaling was activated but not essential for the survival of cells expressing SV40 ST.
Takeaway
The study found that a virus protein changes how human cells survive and respond to drugs, making them more vulnerable to certain treatments.
Methodology
Matched human embryonic kidney cell lines with and without SV40 ST were analyzed using two microarray platforms to compare gene expression.
Limitations
The study primarily focused on two specific cell lines, which may limit the generalizability of the findings.
Participant Demographics
Human embryonic kidney cell lines (HEK-TERST and HEK-TERV).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website